Pure Global
NCT06008301

Comparing Breast Magnetic Resonance Imaging (MRI) and Contrast-enhanced Mammography (CEM)

Comparing Impact of Contrast-enhanced Mammography (CEM) to Breast MRI on Barriers to Breast Cancer Treatment
Boston Medical Center·ClinicalTrials.gov·otherNot yet recruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Breast Cancer Female
Drug/Device/Intervention
State-Trait Anxiety Inventory (STAI)
Study type
Interventional
Intervention type
other
Sponsor & location
Primary sponsor
Boston Medical Center
Timeline & enrollment
Phase
N/A
Start date
Dec 01, 2023
End date
Sep 01, 2025
Enrollment
60 participants
Primary outcome

Institutional financial costs,Patient financial costs,Time from diagnosis to imaging modality (CEM or MRI),Time from diagnosis to first treatment,Number of patient visits generated from the imaging modality,Psychologic costs to patients

Summary

The investigators will study the financial, time, and psychologic benefit of Contrast
 Enhanced Mammography (CEM) compared with Magnetic Resonance Imaging (MRI) for breast cancer
 evaluation and ultimately encourage practices and referring providers to use it more
 routinely in practice.
 
 Specific research objectives are to:
 
 - determine financial costs of performing a CEM to breast MRI
 
 - compare time costs involved with CEM to breast MRI
 
 - compare psychologic costs involved with CEM to breast MRI.

ICD-10 classifications
Malignant neoplasm: Breast, unspecifiedMalignant neoplasm of breastMalignant neoplasm of breastCarcinoma in situ of breast, unspecifiedPersonal history of malignant neoplasm of breast
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06008301
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06008301 through Pure Global AI's free database. This phase not specified trial is sponsored by Boston Medical Center and is currently Not yet recruiting. The study focuses on Breast Cancer Female. Target enrollment is 60 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.